Market Introduction
Protein expression is a process in which proteins are synthesized, modified and regulated. Protein expression involves laboratory techniques & procedures which aid in manufacture of proteins. The technique allows to produce and purify the desired protein, either inside or outside a cell. The proteins synthesized using protein expression technique can be used for industrial processes or to diagnose and to treat diseases.
Thus, the growing adoption of precision medicines are expected to create a significant demand for protein expression in the coming years, which is further anticipated to drive the protein expression market.
The current COVID-19 pandemic has produced a huge immediate demand for SARS-CoV-2 RNA/protein-based diagnostic reagents and associated antibodies, putting tremendous strain on the supply and distribution chain. By achieving rapid, larger-scale production, complemented by long-term higher volume production in transgenic plants, transient expression in plants may resolve the shortage. For example, on Dec. 2020, Clover Biopharmaceuticals, a China-based biotechnology company, announced positive clinical data from its Phase 1 trial demonstrating that its protein-based COVID-19 S-Trimer vaccine candidates in combination with adjuvants from either GSK induce strong immune responses, including neutralizing antibodies and cell-mediated immunity, as well as favorable safety and tolerability profiles in 150 adult and elderly participants. However, in long run the market has strong potential to boost the growth rate as Asia Pacific is most populated region in the world and where high number of Covid 19 cases detected. Also, the prevalence of other infectious diseases and cancer cases.
Market Overview and Dynamics
The Protein expression market in Asia Pacific is expected to grow from US$ 461.2 million in 2021 to US$ 869.7 million by 2028; it is estimated to grow at a CAGR of 9.5% from 2021 to 2028. The COVID-19 pandemic has led to significant health, social, and economic crises. The development of a vaccine for COVID-19 is an effective strategy to control the outbreak. It is required that the vaccine is produced at high speed and is easily scalable. Recombinant protein, viral-vectored or nucleic acid-based (recombinant plasmid DNA and mRNA) vaccines need to be considered to shorten the vaccine production timeframe. The use of protein expression is increasing during vaccine development due to the advantages of recombinant protein, which drives the growth of the protein expression market.
Key Market Segments
In terms of product, the reagents segment accounted for the largest share of the Asia Pacific protein expression market in 2020. In terms of services, the antibody development and production segment accounted for the largest share of the Asia Pacific protein expression market in 2020. In terms of application, the therapeutic segment accounted for the largest share of the Asia Pacific protein expression market in 2020. In terms of end user, the pharmaceutical and biotechnology companies segment accounted for the largest share of the Asia Pacific protein expression market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the protein expression market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Thermo Fisher Scientific Inc., GenScript, Merck KGaA, Agilent Technologies, Inc., Takara Bio Inc., Bio-Rad Laboratories Inc., QIAGEN, New England Biolabs, and Promega Corporation.
Reasons to buy report
- To understand the Asia Pacific Protein expression market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific Protein expression market
- Efficiently plan M&A and partnership deals in Asia Pacific Protein expression market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific Protein expression market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Asia Pacific region.
ASIA PACIFIC PROTEIN EXPRESSION MARKET SEGMENTATION
By Product
- Competent Cells
- Expression Vectors
- Reagents
- Instruments
By Services
- Antibody Development & Production
- Protein Expression & Production
- Hybridoma One-Stop Services
- Stable Cell Line Development
- Bioanalytical Assay Services
By Application
- Research
- Therapeutic
- Industrial
By End User
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Academic Research Institutes
- Others
By Country
-
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
Companies Mentioned
- Thermo Fisher Scientific Inc.
- GenScript
- Merck KGaA
- Agilent Technologies, Inc.
- Takara Bio Inc.
- Bio-Rad Laboratories Inc.
- QIAGEN
- New England Biolabs
- Promega Corporation
Asia Pacific Protein Expression Market Strategic Insights
Asia Pacific Protein ExpressionMarket Report Highlights
| Report Attribute | Details |
| Market size in 2021 | US$ 461.2 Million |
| Market Size by 2028 | US$ 869.7 Million |
| CAGR (2021 - 2028) | 9.5% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| Asia-Pacific | China, India, Japan, Australia, Rest of Asia-Pacific |
| Market leaders and key company profiles |
|
Asia Pacific Protein Expression Market Country and Regional Insights
